TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

12 month price target, page-24

  1. gkm
    331 Posts.
    clock Created with Sketch.
    31/12/10
    12:07
    Post #: 7674635
    good post Panda .. i agree that partner quality will be a very important factor for TIS's market cap going forward. And i believe that the management also knows and understands the same .. which is why there are a number os "large" potential partners in discussion + the independent consultant who is a pioneer in the industry.

    Also TDA's post is a must read .. and the beauty is he had only factored in diabetic ulcers.
    TIS Price at posting: 70.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Strong operational performance drives third consecutive quarter of cash and bullion growth
right-arrow Created with Sketch.
RCE Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
right-arrow Created with Sketch.
NEWS High-grade drilling results at Coda North: impressive intercepts and major milestone achieved
right-arrow Created with Sketch.
NEWS Drilling to kick off at high-priority Bara Creek Prospect, targeting a promising epithermal system near the Bowdens Silver Project
right-arrow Created with Sketch.
NEWS Strong in-fill drill results at Theia deposit bolster plans for resource upgrade, advancing Mandilla's growth potential
right-arrow Created with Sketch.
NEWS High-grade rock chip assays from Titan surface sampling exceed 55% gold and 1,000 g/t silver, unlocking significant exploration potential at this promising prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.